Close Menu

PALM SPRINGS, CALIFORNIA (GenomeWeb) – The 2016 edition of the Mass Spectrometry: Applications to the Clinical Lab US (MSACL) conference highlighted the continued challenges of aligning the technology with the broader agenda of the diagnostics field.

The mass spec-based diagnostics field is like a water balloon; it is set to be squeezed on one end by impending regulation of laboratory-developed tests, but also to expand as matrix-assisted laser desorption/ionization (MALDI) mass spec platforms gain greater adoption in the clinical market.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The US National Institutes of Health's All of Us project awarded $4.6 million to the company Color to develop a genetic counseling resource for the program.

The Times of India reports on a pilot study that used genomic testing to determine whether patients had drug-resistant tuberculosis.

New guidelines say that more women may benefit from genetic testing for hereditary breast or ovarian cancer, according to the Los Angeles Times.

In Cell this week: small proteins identified among human microbiome, role for tumor microbes in pancreatic cancer survival, and more.

Aug
22
Sponsored by
BC Platforms

This webinar will discuss how the Estonian Biobank, a cohort of more than 165,000 participants, is addressing industry challenges with data management and collaboration in the transition to precision medicine.

Oct
23
Sponsored by
Swift Biosciences

This webinar will illustrate how single-cell methylation sequencing can be applied to gain significant insight into epigenetic heterogeneity in disease states, advancing cancer research discoveries.